EP029/#364 3-year survival and risk of cancer progression and premature death caused by breast cancer in Georgia

Abstract

was noticed in 15% of cases and 15% used oestrogen-progestin combination as a contraceptive method. Fifty six percent of patients were diagnosed with stage 2 disease and 20% with stage 4. Pathological subtype was invasive ductal carcinoma in 92% of cases and 80% were triple negative. Treatment strategy was mainly based on a radical surgery with radiotherapy and chemotherapy. During the follow up period, metastatic disease occurred in 15% of cases. Five patients died due to disease progression. Overall survival after treatment was about 86%. Conclusions Young breast cancer patients seem to have a more aggressive disease course. That's why the management of this special patient population requires an interdisciplinary approach.